...
首页> 外文期刊>FEMS immunology and medical microbiology >The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent.
【24h】

The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent.

机译:幽门螺杆菌的中性粒细胞激活蛋白(HP-NAP)作为免疫调节剂。

获取原文
获取原文并翻译 | 示例
           

摘要

During evolution microorganisms have developed several immune modulating strategies. The Helicobacter pylori neutrophil-activating protein (HP-NAP) is a virulence factor that attracts and activates neutrophils, and promotes their endothelial adhesion and the production of oxygen radicals and chemokines, including CXCL8, CCL3 and CCL4. HP-NAP, a TLR2 agonist, is an immune modulator able to induce the expression of interleukin-12 (IL-12) and IL-23 by human neutrophils and monocytes. In fact, HP-NAP has the potential to shift antigen-specific T-cell responses from a predominant Th2 to a polarized Th1 cytotoxic phenotype, characterized by high levels of interferon-gamma and tumor necrosis factor-alpha production. Thus, HP-NAP is a key factor driving Th1 inflammation in H. pylori infection and may be a new tool for future therapeutic strategies aimed at redirecting Th2 into Th1 responses, for example in atopy, vaccinology and cancer immunotherapy.
机译:在进化过程中,微生物已开发出几种免疫调节策略。幽门螺杆菌嗜中性粒细胞激活蛋白(HP-NAP)是一种毒性因子,可吸引和激活嗜中性粒细胞,并促进其内皮粘附以及促进氧自由基和趋化因子(包括CXCL8,CCL3和CCL4)的产生。 HP-NAP是TLR2激动剂,是一种免疫调节剂,能够诱导人嗜中性粒细胞和单核细胞表达白介素12(IL-12)和IL-23。实际上,HP-NAP有潜力将抗原特异性T细胞反应从主要的Th2转变为极化的Th1细胞毒性表型,其特征在于高水平的干扰素-γ和肿瘤坏死因子-α产生。因此,HP-NAP是在幽门螺杆菌感染中驱动Th1炎症的关键因素,并且可能是未来治疗策略的新工具,旨在将Th2重新定向为Th1反应,例如在特应性,疫苗学和癌症免疫疗法中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号